Boehringer Ingelheim, in collaboration with Agripac’s Consumer Division, officially launched Vetmedin in the cities of Quito and Guayaquil.
The event featured international specialists who shared technical information about the product and its benefits in treating heart disease in dogs.
Vetmedin is indicated for the treatment of congestive heart failure due to atrioventricular valvular insufficiency or dilated cardiomyopathy. It can also be used in preclinical stages to delay the onset of clinical signs, contributing to a better quality of life for canine patients.
The events were attended by leading veterinary clients from across the country, who experienced first-hand the scientific backing and effectiveness of this innovative treatment. Without a doubt, it was a high-value technical and commercial event that strengthened ties with our partners in the veterinary sector.
